Abstract
Background
Although antimyosin scintigraphy detects myocyte necrosis associated with myocarditis, it has also been reported to yield positive results in a large number of patients with clinical dilated cardiomyopathy without histologic evidence of myocarditis. The question to be resolved is whether this discordance represents false-positive results of antimyosin scans or whether antimyosin scintigraphy more accurately identifies the presence of myocyte necrosis than does endomyocardial biopsy testing.
Methods and Results
Forty patients with the acute onset of dilated cardiomyopathy (left ventricular ejection fraction <45%; mean 27%±11%) but no endomyocardial biopsy evidence of myocarditis, were identified from a consecutive series of 50 patients who had undergone indium 111 antimyosin antibody scintigraphy and endomyocardial biopsy for suspected myocarditis. The endomyocardial biopsy specimens were analyzed to identify features correlating with antimyosin uptake or improvement in left ventricular ejection fraction (LVEF) over time. Twenty-five patients showed left ventricular myocardial uptake of radiolabeled antimyosin antibody by both planar and tomographic imaging. The remaining 15 patients had no antimyosin uptake. Of the 25, 22 (88%) patients with positive findings on antimyosin scans had degenerated, myofibrillarlytic myocytes in their biopsy specimens. Of the 15 patients with negative findings on antimyosin scans, only 6 (40%) had similar myofibrillarlytic myocytes (χ2; p<0.0047). No other histological feature correlated with the antimyosin positivity. Stepwise multiple regression analysis was performed for identification of predictors of short-term improvement in LVEF. Patients with positive findings on antimyosin scans showed a trend toward improvement with time (F=3.97; p>0.05). None of the histologic features predicted improvement in the LVEF. However, the combination of positive findings on an antimyosin scan and myofibrillarlysis did correlate significantly with spontaneous improvement in ejection fraction (F=4.53; 0.01; <p<0.05).
Conclusions
This study identifies myofibrillarlysis as a common pathologic alteration in patients with recent onset of dilated cardiomyopathy and positive findings on antimyosin scan, who lack right ventricular biopsy evidence of myocarditis. Because myofibrillarlytic cell population may represent a histologic spectrum of viable to necrotic myocytes, it appears that antimyosin uptake detects necrotic myofibrillarlytic myocytes that are not identified by light microscopy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Khaw BA, Scott J, Fallon JT, Haber E. Myocardial injury quantitation by cell sorting method with antimyosin fluorescent microspheres. Science 1982;217:1050–3.
Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation 1986;74:501–8.
Khaw BA, Yasuda T, Gold HK, et al. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. J Nucl Med 1987;28:1671–8.
Narula J, Khaw BA, Dec GW, et al. Recognition of myocarditius masquerading as acute myocardial infarction. N Engl J Med 1993;328:100–4.
StraussHW, Narula J, Khaw BA, eds. Monoclonal antibodies in cardiovascular diseases. Philadelphia: Lea & Febiger, 1994.
Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis a histopathological definition and classification. Am J Cardiovasc Pathol 1987;1:3–14.
Yasuda T, Palacios IF, Dec GW, et al. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 1987;76:306–11.
Dec GW, Palacios I, Yasuda T, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990;16:97–104.
Dec GW, Palacios IF, Fallon JT et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histopathological correlates, and clinical outcome. N Engl J Med 1985;312:885–90.
Mason JW, Billingham ME, Ricci DR. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol 1980;45:1037–44.
Parrillo JE, Aretz HT, Palacios IF, Fallon JT, Block PC. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 1984;69:93–101.
Dec GW, Fallon JT, Southern JF, Palacios IF. “Borderline” myocarditis: an indication for repeat endomyocardial biopsy. J Am Coll Cardiol 1990;15:283–9.
Dick MR, Unverferth DV, Baba N. The pattern of myocardial degeneration in non-ischemic congestive cardiomyopathy. Human Pathol 1982;13:740–4.
Unverferth DV, Magorien RD, Lewis RP, Leier CV. The role of subendocardial ischemia in perpetuating myocardial failure in patients with non-ischemic cardiomyopathy. Am Heart J 1983;105:176–9.
Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI. BMDP statistical software manual. Vol. 2. Berkeley, California: University of California Press, 1988:1045.
Morrison DF. Multivariate statistical methods. New York: Mc-Graw-Hill, 1976:33–4.
Pearson K. On a criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philos Mag 1900;50:157–75.
Carrio I, Pousa AL, Estorch M, et al. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111 antimyosin monoclonal antibody studies. J Nucl Med 1993;34:1503–7.
Edwalds GM, Said JW, Block MI, Herscher LL, Siegel RJ, Fishbein MC. Myocytolysis (vacoular degeneration) of myocardium: immunohistochemical evidence of viability. Human Pathol 1984;15:753–6.
Flameng W, Suy R, Schwarz F, et al. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy post-revascularization surgery. Am Heart J 1981;102:846–57.
Geer JC, Crago CA, Little WC, Gardner LL, Bishop SP. Subendocardial ischemic myocardial lesions associated with coronary atherosclerosis. Am J Pathol 1980;8:663–80.
Schlesinger MJ, Reiner L. Focal myocytolysis of the heart. Am J Pathol 1955;31:443–59.
Schwartz CJ, Mitchell JRA. The relation between myocardial lesion and coronary artery disease: an unselected necropsy study. Br Heart J 1962;24:761–86.
Narula J, Strauss HW, Khaw BA. Antimyosin positivity in doxorubicin toxicity: earlier than the conventional evidence! J Nucl Med 1993;34:1507–9.
Ballester RM, Obrador MD, Carrio I, et al. Indium-11 monoclonal antimyosin antibody studies after the first year of heart transplantation: identification of the risk groups for developing rejection during long-term follow-up and clinical implications. Circulation 1992;82:2100–8.
Green NM. Electron microscopy of the immunoglobulins. Adv Immunol 1969;11:1–30.
Podack ER. Molecular mechanisms of cytolysis by complement and cytolytic lymphocytes. J Cell Biochem 1986;30:133–70.
Amit AG, Mariuzza RA, Phillips SEV, Poljak RJ. Three-dimensional structure of an antigen antibody complex at 2.8 Å resolution. Science 1986;233:747–53.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Narula, J., Southern, J.F., Dec, G.W. et al. Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy. J Nucl Cardiol 2, 470–477 (1995). https://doi.org/10.1016/S1071-3581(05)80038-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/S1071-3581(05)80038-8